Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer.

J Immunother Cancer · 2025 · PMC11931939 · PMID 40121029

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Plotting of CXCL5 protein by stage was statistically insignificant (p=0.069) but showed a positive trend ( online supplemental figure 1C ).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.